Tag Archives: Lumpectomy

PUBLISHED: Left Lumpectomy with Wireless Seed Localization for Ductal Carcinoma In Situ

Left Lumpectomy with Wireless Seed Localization for Ductal Carcinoma In Situ
Massachusetts General Hospital

Bridget N. Kelly
MGH

Carson L. Brown
MGH

Michelle C. Specht, MD
Operating Surgeon, MGH

The patient in this case is a 58-year-old postmenopausal woman who was seen for consultation regarding the management of newly-diagnosed ductal carcinoma in situ (DCIS) of the left breast detected on routine screening mammogram with no clinical or radiological evidence of lymph node involvement.

Breast-conserving surgery with radiation for early-stage breast cancers provides equivalent survival rates to mastectomy when all surgical margins are clear of residual cancer. For patients whose tumors are not palpable upon physical examination, preoperative localization of the malignant tissue to be removed is necessary.

In this video, Dr. Specht at MGH performs and narrates a lumpectomy using wireless seed localization to target the lesion and taking shave margins to reduce the risk of recurrence.


PREPRINT RELEASE: Left Lumpectomy with Wireless Seed Localization


Left Lumpectomy with Wireless Seed Localization
Massachusetts General Hospital

Michelle C. Specht, MD
Assistant Professor of Surgery
Harvard Medical School

On screening mammogram, the patient in this case was found to have ductal carcinoma in situ with calcifications and an area of concern measuring around 2.5 cm. In this video, Dr. Specht performs and narrates a left lumpectomy and explains how to use wireless seed localization in order to more accurately excise the affected area and reduce the risk of recurrence.

PREPRINT RELEASE: Lumpectomy with Sentinel Node Biopsy

Lumpectomy with Sentinel Node Biopsy
Massachusetts General Hospital

Barbara Smith, MD, PhD
Professor of Surgery
Harvard Medical School

Dr. Barbara Smith at MGH performs a lumpectomy and sentinel lymph node biopsy on a female patient who had palpable breast cancer. This case was part of a study featuring Lumicell technology, which looks for residual tumor following the lumpectomy with the goal of reducing rates of recurrence.